Cite

HARVARD Citation

    Heery, C. et al. (n.d.). Phase I, dose-escalation, clinical trial of MVA-Brachyury-TRICOM vaccine demonstrating safety and brachyury-specific T cell responses. Journal for immunotherapy of cancer. p. . [Online]. 
  
Back to record